Effect of Exercise in Pediatric Hemophilia

February 11, 2021 updated by: Tuğba GÖNEN, Hasan Kalyoncu University

The Effect of Exercise Training on Pain, Physical Activity and Quality of Life in Pediatric Hemophilia Patients

This study investigates the effect of exercise training on pain, physical activity and quality of life in pediatric hemophilia patients.

Study Overview

Detailed Description

Hemophilia is a congenital X-linked recessive disease characterized by the lack or absence of clotting factors in the blood. Male individuals with problems in the X chromosome are affected, females are carriers. There are two common types, factor VIII (Hemophilia A) and factor IX (Hemophilia B), and the percentage of the exposed factor in circulation determines the degree of hemophilia disease (<1% severe, 1-5% moderate,> 20% mild). The most common clinical symptoms in hemophilia are intra-articular and intramuscular spontaneous bleeding, a history of bleeding that lasts longer than expected after trauma, hemarthrosis and hematomas after crawling or walking in children with moderate or severe hemophilia. Pain, swelling, redness, temperature increase and limitation of movement occur in the bleeding joint. Bleeding into the joint space causes inflammation in the synovial membrane and synovitis occurs. With chronic synovitis, the synovial membrane thickens. Degeneration of the joint cartilage and narrowing of the joint space occurs. Hemarthroses constitute 70-80% of bleeding findings. The most common bleeding joints are knee joints with a rate of 45%. Besides pharmacological treatment for joint and muscle bleeding, the most suitable option is exercise therapy.

The aim of our study is to examine the effect of exercise agitation on pain, physical activity and quality of life in pediatric hemophilia patients. The results of the study indicate that the exercise protocol developed for the lower extremity in pediatric hemophilia patients will have a positive effect on pain, physical activity and quality of life.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Şahinbey
      • Gaziantep, Şahinbey, Turkey, 27100
        • Hasan Kalyoncu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Diagnosed with hemophilia (Hemophilia A) by a hematologist
  • Hemophilia is moderate or severe, without spontaneous bleeding complaints
  • Having a history of bleeding in the knee joint
  • Not doing any regular exercise
  • Willing to continue working and will not start other treatment during the study
  • Patients whose parents were informed about the study and whose consent form was obtained

Exclusion Criteria:

  • Those who have undergone another surgery (joint debridement, fracture, knee replacement) that will affect lower extremity function
  • Those with neurological disease or any sensory loss or peripheral nerve injury that may affect functional performance and balance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control group
This group will not take any exercise intervention.
ACTIVE_COMPARATOR: Traditional exercise training group
This group will get traditional therapy that is include range of motion exercises and resistance exercise training.
The therapy program will planned for 12 weeks and the sessions will be performed in 45 minutes (min) for 2 days a week. The lower extremity range of motion exercise and strengthening exercises will be applied on the mat 10 repetition. The number of repetitions and type of exercises will be changed every 3 weeks.
EXPERIMENTAL: Specific exercise training group
This group will get a specific programme that combinated with closed kinetic chain exercises and core exercises training
The therapy program will planned for 12 weeks and the sessions will be performed in 45 minutes (min) for 2 days a week. Exercise training consists of lower extremity closed kinetic chain exercises and core exercises. The type of exercise changes every 3 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Pain
Time Frame: through of the study, average 12 weeks
Mc Gill Short Form will used to determine the type and severity of the pain. A short form of the McGill Pain Questionnaire (SF-MPQ) has been developed. The main component of the SF-MPQ consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe.
through of the study, average 12 weeks
Functional ambulatory mobility
Time Frame: through of the study, average 12 weeks
Time Up and Go test will used to determine ambulatory mobility. Time up and go test required documenting the time in seconds that subjects required to: "rise from a standard arm chair, walk to a line on the floor 3 meters away, turn, return, and sit down again." If relapsed time score is increased, that is mean mobility function will worse.
through of the study, average 12 weeks
Functional exercise capacity
Time Frame: through of the study, average 12 weeks
Two minutes walk test will used to determine physical activity. 2-minute walk test (2MWT) is classified to represent the most suitable method to assess the submaximal level of functional exercise capacity in children. This test measures the distance that a patient or participant quickly walk on a flat, hard surface in a period of 2 minutes.If the covered distance is increased, that is mean functional capacity will worse.
through of the study, average 12 weeks
Lower extremity functional strength test
Time Frame: through of the study, average 12 weeks
Sit to stand test will used to determine physical activity. The sit-to-stand test measures time needed to complete three consecutive sit-to-stand cycles as quickly as possible. The higher the rate of three-repetition sit-to-stand (repetitions per second), the more strength a children has.
through of the study, average 12 weeks
The quality of Life
Time Frame: through of the study, average 12 weeks
The Children's Quality of Life Scale ( PedsQL) will used to determine to quality of life level. The quality of life scale for children questions the last month of children and adolescents. It is a 5-point Likert-type scale with never 100 points, rarely 75 points, sometimes 50 points, often 25 points and always 0 points. The total score is obtained by dividing the scores obtained from the scale by the number of filled items. The higher the total score, the better the quality of life.
through of the study, average 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Proprioception
Time Frame: through of the study, average 12 weeks
Electro goniometer measurement will used to determine knee proprioception
through of the study, average 12 weeks
Joint Health
Time Frame: through of the study, average 12 weeks
Hemophilia Joint Health Scale will used to determine bilaterally knee, elbow and ankle joint health. Total score of the scale is 124 point. The higher score of the scale, the more deficit joints have.
through of the study, average 12 weeks
Functional Independence
Time Frame: through of the study, average 12 weeks
Functional Independence Score in Hemophilia (FISH) will used to functional independence. FISH is based on observing the performance of daily life activities. Patients are assessed for their ability to perform eight tasks, divided into three categories: self-care (eating, grooming, bathing and dressing), transfers (chair and squatting) and mobility (walking, going up stairs and running).The scores achieved in each task are summed giving a total from 8 to 32 points with 32 indicating the highest level of functional independence
through of the study, average 12 weeks
Static Balance
Time Frame: through of the study, average 12 weeks
Stand on one leg test was used assess static balance
through of the study, average 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 16, 2021

Primary Completion (ANTICIPATED)

November 10, 2021

Study Completion (ANTICIPATED)

November 30, 2021

Study Registration Dates

First Submitted

February 8, 2021

First Submitted That Met QC Criteria

February 11, 2021

First Posted (ACTUAL)

February 15, 2021

Study Record Updates

Last Update Posted (ACTUAL)

February 15, 2021

Last Update Submitted That Met QC Criteria

February 11, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemophilia Arthropathy

Clinical Trials on Traditional exercise training

3
Subscribe